Adjuvant PD-1/PD-L1 Inhibitors Demonstrate Effectiveness While Raising Safety Concerns in Solid Tumors
Programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors have emerged as transformative agents in oncology, revolutionizing the ...
